Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 2592 Posts
1 2 3 ... 162
5 Of Today's Biggest Marijuana Stock Losers - Thursday, August 16
Article By: The Daily Marijuana Observer
Thursday, August 16, 2018 11:00 PM EDT
Here are 5 of the biggest marijuana stock losers in trading on Thursday, August 16th.
In this article: AHGIF, BXNG, CANN, PNTV, VRTHF
Read
5 Of Today's Biggest Marijuana Stock Losers - Wednesday, August 15
Article By: The Daily Marijuana Observer
Wednesday, August 15, 2018 10:47 PM EDT
Here are 5 of the biggest marijuana stock losers in trading on Wednesday, August 15th
In this article: ACOL, EVIO, MSRT, MICWF, SRNA
Read
5 Of Today's Biggest Marijuana Stock Gainers - Tuesday, August 14
Article By: The Daily Marijuana Observer
Tuesday, August 14, 2018 11:10 PM EDT
Here are 5 of the biggest marijuana stock winners in trading on Tuesday, August 14th.
In this article: BXNG, CLSH, CVSI, IGC, SLTK
Read
Biotech ETFs In Focus On String Of Q2 Earnings Beats
Article By: Zacks Investment Research
Sunday, August 12, 2018 4:27 PM EDT
The biotech sector has been performing remarkably well driven by a wave of mergers and acquisitions, new tax legislation, and a positive regulatory backdrop. Strong Q2 earnings results have added to the strength as biotech giants topped estimates.
In this article: IBB, AMGN, GILD, BBH, FBT, ALXN, BIIB
Read
New Diabetes Solutions Tapping Our Disruptive Innovators And Digital Lifestyle Investing Themes
Article By: Tematica Research
Sunday, August 12, 2018 11:48 AM EDT
When it comes to the market that is diabetes we are seeing a number of new products and services that incorporate new or existing technologies to offer an easier consumer experience and make managing diabetes far easier and less painful.
In this article: ABT, MDT
Read
Week In Review: Shanghai Junshi Biosciences Files For $500 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, August 11, 2018 7:27 PM EDT
Shanghai Junshi Biosciences has filed for a Hong Kong IPO that is expected to raise up to $500 million. Junshi is developing a pipeline of 13 biologic drugs, including immuno-oncology treatments.
In this article: SGYP, CELG, GILD, CANF, BGNE
Read
Biopharma Portfolio 2018 YTD: Performance Summary
Article By: Rod Raynovich
Friday, August 10, 2018 11:59 AM EDT
The best way to make money in biotechnology is to hold the best companies over the long-term.
In this article: FBT Also: RHHBY, IBB, CELG, NBIX, XLV, SRPT, BLUE, FMI, LOXO
Read
Biotech Snapshot During A Rally Day: No Summer Doldrums…
Article By: Rod Raynovich
Friday, August 10, 2018 5:06 AM EDT
Biotech stocks were mixed trading closer to the flatline after the close last night, on light summer volume. Macro issues such as drug pricing, trade and the Fed remain a concern.
In this article: ALNY, IBB, CELG, GILD, NKTR, FBT, XBI, XLV, ABBV, SRPT, TSRO, EDIT, NTLA, CRSP, SGMO
Read
Progenics Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, August 8, 2018 5:22 AM EDT
Progenics Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 9,090,909 primary shares of its common stock at a public offering price of $8.25 per share.
In this article: PGNX
Read
Q2 Earnings Drive Pharma ETFs Higher
Article By: Sweta Killa
Tuesday, August 7, 2018 12:23 PM EDT
Total earnings for 83.5% of the total healthcare market capitalization are up 13.7% on revenue growth of 7.8%.
In this article: IHE, PJP, PPH, XPH, FTXH Also: BMY, JNJ, LLY, MRK, PFE
Read
How Industrial Hemp Could Drive Growth In The Cannabis Industry
Article By: Maithya Kitonyi
Tuesday, August 7, 2018 5:52 AM EDT
Medical cannabis has been one of the main drivers of growth in the global cannabis market but now industrial hemp appears to be gaining traction with a projected CAGR growth of 14% through 2025.
In this article: HEMP, GWPH
Read
Week In Review: Two Hong Kong IPOs - BeiGene And Ascletis - Raise A Combined $1.3 Billion
Article By: ChinaBio® Today
Saturday, August 4, 2018 4:27 PM EDT
BeiGene, a Beijing oncology company, raised $900 million in a debut offering on the Hong Kong stock exchange. Ascletis Pharma of Hangzhou completed a $400 million IPO on the Hong Kong exchange at a $2 billion capitalization
In this article: AMGN, BGNE
Read
3 Canadian LP's Making Major Headlines
Article By: Technical420
Friday, August 3, 2018 1:11 PM EDT
The Canadian cannabis sector has been trading lower on average recently and we are monitoring the recent decline. Although the sector has been under pressure, companies continue to execute and advance their story.
In this article: HYYDF, APHQF, EMMBF
Read
Q2 Earnings Update: Bluebird Bio (BLUE) And Regeneron (REGN)
Article By: Rod Raynovich
Thursday, August 2, 2018 11:09 PM EDT
Regeneron Pharmaceuticals (REGN) soared 7% to $397 on earnings beat with adjusted EPS of $5.45. Bluebird Bio (BLUE) was up 0.79% to $156.60 despite losses and lagging revenue.
In this article: BLUE, REGN
Read
5 Cheap PEG Stocks Suitable For GARP Investors
Article By: Zacks Investment Research
Thursday, August 2, 2018 1:12 PM EDT
Investors seeking long-term growth often wonder whether they should resort to any of the fundamental strategies like growth or value. Going by Warren Buffett, these two approaches are joined at the hip.
In this article: HCA, TMO, BIIB, GILD, QCOM
Read
Teva (TEVA) Beats On Q2 Earnings, Misses Sales, Shares Dip
Article By: Zacks Investment Research
Thursday, August 2, 2018 10:45 AM EDT
Teva’s second-quarter earnings came in at 78 cents per share which beat consensus estimate of 67 cents. Teva posted revenues of $4.70 billion, which missed consensus estimates of $4.76 billion. Sales declined 18%.
In this article: TEVA
Read
1 to 16 of 2592 Posts
1 2 3 ... 162